Myriad Genetics (MYGN) Research & Development (2016 - 2025)
Historic Research & Development for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $28.2 million.
- Myriad Genetics' Research & Development fell 105.26% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.5 million, marking a year-over-year increase of 1182.27%. This contributed to the annual value of $113.4 million for FY2024, which is 2784.67% up from last year.
- Per Myriad Genetics' latest filing, its Research & Development stood at $28.2 million for Q3 2025, which was down 105.26% from $25.6 million recorded in Q2 2025.
- Over the past 5 years, Myriad Genetics' Research & Development peaked at $32.2 million during Q4 2024, and registered a low of $18.8 million during Q3 2021.
- For the 5-year period, Myriad Genetics' Research & Development averaged around $23.7 million, with its median value being $23.1 million (2021).
- Per our database at Business Quant, Myriad Genetics' Research & Development plummeted by 4273.74% in 2021 and then skyrocketed by 5333.33% in 2024.
- Myriad Genetics' Research & Development (Quarter) stood at $20.5 million in 2021, then increased by 14.15% to $23.4 million in 2022, then fell by 10.26% to $21.0 million in 2023, then skyrocketed by 53.33% to $32.2 million in 2024, then decreased by 12.42% to $28.2 million in 2025.
- Its last three reported values are $28.2 million in Q3 2025, $25.6 million for Q2 2025, and $27.5 million during Q1 2025.